Please login to the form below

Not currently logged in
Email:
Password:

Elijah Cummings

This page shows the latest Elijah Cummings news and features for those working in and with pharma, biotech and healthcare.

Teva among generic drugmakers hoping to settle US antitrust probe

Teva among generic drugmakers hoping to settle US antitrust probe

The politicians, including potential presidential candidate Bernie Sanders and Chairman of the House Committee on Oversight and Reform Elijah Cummings, asked the company for the same data on sales and expenditures

Latest news

  • US politicians round on generics firms for blocking drug pricing probe US politicians round on generics firms for blocking drug pricing probe

    That’s when Elijah Cummings, the Chairman of the House Committee on Oversight and Reform, and Sanders wrote to the companies seeking information about the “dramatic increase in generic drug prices”. ... In the letter, Cummings and Sanders note that

  • Marathon pauses Emflaza launch amid pricing furore Marathon pauses Emflaza launch amid pricing furore

    dystrophy. US politicians including Senator Bernie Sanders and Representative Elijah Cummings have the company firmly in their sights, saying that the pricing is "unconscionable", and suggesting the firm is abusing ... premiums. Sanders and Cummings say

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics